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Opitz G/BBB syndrome, a defect of 
midline development, is due to mutations 
in a new RING finger gene on Xp22
Nandita A. Quaderi1, Susann Schweiger2, Karin Gaudenz3, Brunella Franco1, Elena I. Rugarli1, Wolfgang Berger2, 
George J. Feldman3, Manuela Volta1, Grazia Andolfi1, S. Gilgenkrantz4, Robert W. Marion5, 
Raoul C.M. Hennekam6, lohn M. Opitz7, Maximilian Muenke3, H. Hilger Ropers2,8 & Andrea Ballabio1
Opitz syndrome (OS) is an inherited disorder characterized by midline defects including hypertelorism, hypospadias, 
lip-palate-laryngotracheal clefts and imperforate anus. We have identified a new gene on Xp22, MiD1 (Midline 1), 
which is disrupted in an OS patient carrying an X-chromosome inversion and is also mutated in several OS families. 
MIDI encodes a member of the B-box family of proteins, which contain protein-protein interaction domains, 
including a RING finger, and are implicated in fundamental processes such as body axis patterning and control of 
cell proliferation. The association of MIDI with OS suggests an important role for this gene in midline development
Opitz G/BBB syndrome (OS; McKusick 145410 and 300000) is an 
inherited multiple-organ disorder primarily affecting midline 
structures. The disorder was first reported as two separate enti­
ties, BBB syndrome1 and G syndrome2. Since then it has become 
apparent that the two syndromes are in fact a single entity, now 
named the Opitz G/BBB syndrome, OS is characterized by a con- 
vStellation of symptoms, including hypertelorism; clefts of lip, 
palate and uvula; laryngotracheo-oesophageal abnormalities, 
leading to swallowing difficulty and hoarse cry; genito-urinary 
defects, such as hypospadias in males and splayed labia majora in 
females; imperforate anus; developmental delay; and congenital 
heart defects. The phenotype (Fig. 1) is more complex and more 
severe in male than in female patients3"16. OS is not only one of 
several X-linked syndromic mental retardation disorders but also 
one of the few mendelian inherited forms of cleft lip and palate, 
A recent linkage study conducted on ten families segregating 
the OS phenotype revealed genetic heterogeneity for this disor­
der, In that study, the disorder was linked to DXS987 in Xp22 in 
three families, with a lod score of 3.53 at zero recombination, 
while it was linked to D22S345 from chromosome 22ql 1.2 in five 
families (ref. 17). Confirmation of the Xp22 localization came 
from a second study, in which linkage of the OS locus to 
DXS7104 in Xp22 was reported18. The X-linked and autosomal 
forms of the disease cannot be differentiated on the basis of the 
clinical phenotype'1. Further evidence for an X-linked form of
OS was provided by the description of a large French family in 
which the disease appeared to co-segregate with a pericentric 
inversion of the X chromosome inv(X)(p22.3q26). In this three- 
generation family, four boys, their mothers and their maternal 
grandmother showed the typical manifestations of OS, and all of 
the symptomatic patients had the X-chromosome inversion19. 
The combination of linkage and inversion breakpoint data indi­
cated Xp22.3 as the critical region for the OS gene.
As the anomalies observed in OS p r im a r i ly  affect midline 
structures, it has been proposed that genes important to human 
development, such as zinc-flnger genes, would be good candi­
dates for OS17. To identify the X-linked OS gene, we undertook a 
positional cloning approach to precisely localize the inversion 
breakpoint and identify transcribed sequences from the 
region20,21. Our efforts led to the identification of a new gene, 
MIDI (Midline 1), which spans the OS inversion breakpoint. 
The MIDI protein belongs to a family of transcriptional regula­
tors that contain protein-protein interaction domains and have 
been implicated in fundamental processes such as body axis pat­
terning22"25 and cell transformation26,27. The identification of 
mutations in affected individuals demonstrates that MIDI is the 
gene for X-linked OS.
Fine localization of the Xp22 inversion breakpoint
An X-chromosome pericentric inversion, with breakpoints in 
Xp22 and Xq26, was found in affected individuals from a twenty- 
member OS family19. To localize the Xp22 inversion breakpoint, 
we performed fluorescence in situ hybridization (FISH) on chro­
mosome spreads from individuals carrying the inverted X chro­
mosome and a normal control, using as probes YAC clones 
known to map to Xp22 (ref. 20). The overlapping YACs 184F6 
and 61B3 (ref. 20) gave two signals on the inverted X chromo­
some (on Xp22 and Xq26), indicating that they spanned the 
breakpoint (data not shown). Cosmid clones from the region 
covered by YAC 184F6 (ref. 28 and Cox et al., submitted) were 
then hybridized by FISH to chromosome spreads from affected 
individuals carrying the inverted X chromosome, and subse­
quently to digested genomic DNA derived from affected and nor­
mal individuals. The results indicate that the Xp22 inversion
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breakpoint lies within the region of overlap between cosmid 
U143A10 and U202D11 (Fig. 2). We observed an abnormal band­
ing pattern by hybridizing a pool of three EcoRI subclones derived 
from cosmid U143A10 to digested genomic DNA from affected 
individuals carrying the inverted X chromosome, as compared to 
a normal female control (data not shown).
Isolation of MIDI cDNA clones
During our efforts to construct a transcription map of the Xp22 
region, we performed exon-trapping experiments on the cos- 
mids contained in a previously described contig28. Several exon- 
trapping products were identified. Sequence analysis of two 
exon-trapping products (6H and 10a) derived from cosmid 
U232B2 (Fig. 2) revealed nucleotide sequence identity with a 
cluster o f  seventeen overlapping ESTs. This cluster of ESTs had 
previously been mapped to the large interval between DXS1223 
and DXS999 in Xp22 (ref. 29). A 1.8-kb infant brain cDNA clone 
(c-lzhlO) containing ESTs Z44417 and Z40343 was used as a 
hybridization probe against a differentiated hNT2 neuron cDNA 
library, and twenty-three primary positive clones were isolated, 
seven of which were randomly selected for further study. Using 
both  cDNA-specific and vector primers, we characterized these 
seven cDNA clones by end-sequencing, restriction mapping and 
PCR. A consensus cDNA sequence of 3,452 bp was assembled. 
We validated the authenticity of the 5' end of the cDNA by 
sequencing the corresponding genomic region* The putative ini­
tiation codon was identified at position 187 bp and is located 
within a nucleotide sequence that fulfils Kozak's criteria30. An in­
frame stop codon (TGA) was detected 48 nucleotides upstream 
of this putative initiation codon. The first downstream in-frame 
stop codon (TGA) was identified at nucleotide position 2188, 
resulting in a coding region of 2,001 bp with a predicted protein 
product of 667 amino acids (Fig. 3a). Preliminary characteriza­
tion of additional cDNA clones suggests that MIDI is subject to 
extensive alternative splicing in the 5' UTR (data not shown). No 
splice variants in the MIDI coding region have been detected.
An X-chromosome inversion associated with OS 
disrupts MIDI
Hybridization o f  the complete MIDI cDNA to YAC clones assigned 
to the Xp22 region revealed three positive clones (YACs 184F6, 
61B3 and NB2E12) known to map in the interval between 
DXS1136 and DXF22S5 (ref. 20), containing the OS inversion 
breakpoint (data not shown). FISH analysis with the full-length 
MIDI cDNA on a chromosome spread derived from a male cell line 
showed a unique signal on Xp22, indicating that MIDI represents a 
single-copy X-linked locus (data not shown). EcoRl-digested cos­
mid clones from the region covered by YAC 184F6 were hybridized
T E L
Fig. 1 A patient with X-linked OS. This 
patient belongs to family OS16 (patient 
1644). The hypertelorism, telecanthi, mild 
entropion of lower eyelid, high nasal bridge 
and surgically corrected cleft lip are evident.
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with the full-length MIDI cDNA.
The cosmid clones U232B2, U11D6,
U239F12, U8D11, U202D1I and 
U76G12 were observed to be positive 
(Fig. 2). The MIDI genomic locus 
spans a total of eleven overlapping 
cosmid clones, representing approxi­
mately 300 kb (Fig. 2). Hybridiza­
tion using subclones/oligonucleotide probes derived from the 5' 
and 3' regions of the MIDI cDNA demonstrated that the direction 
of transcription is orientated from the centromere to Xpter, with 
the initial methionine codon located in cosmid USD 11 (Fig, 2). 
Together, these data demonstrate that the 5' end of MIDI spans the 
OS inversion breakpoint, suggesting that the disease phenotype 
displayed by individuals carrying the inverted X chromosome is 
caused by impaired MIDI transcription. Furthermore, Southern- 
blot analysis of DNA from somatic-cell hybrids retaining the 
abnormal X chromosome revealed that MIDI  is deleted in two 
female patients (BA95 and BA333; ref. 31, pers. comm.) with de 
novo Xp22;Yql 1 translocations (data not shown).
MIDI expression
The MIDI  cDNA was hybridized against commercially available 
northern blots containing polyA’1" RNA extracted from a variety 
of fetal and adult hum an tissues (Fig. 4^,/?). A -7-lcb transcript 
and a fainter ~3.5-kb transcript were observed in all tissues pres­
ent. In fetal organs, the kidney showed the highest level of MIDI  
expression, followed by brain and lung. MIDI  appears to be 
expressed at relatively low levels in fetal liver. In the adult tissues, 
MIDI  expression is most abundant in the heart, placenta and 
brain. We investigated MIDI  expression in an affected male from 
the family carrying the pericentric X-chromosome inversion. 
RT-PCR analysis showed absence of MIDI  expression in the af­
fected male, whereas an amplification product of expected size 
was seen in the control (data not shown). A control RT-PCR, 
using primers derived from an independent locus, was per­
formed in parallel and amplified both the affected and unaf­
fected individuals (data not shown).
To begin investigating the spatio-temporal expression pattern of 
MIDI  during development, we isolated a partial murine cDNA 
and performed preliminary RNA in situ hybridization studies on 
whole-mount mouse embryos. These experiments confirmed that
Midi is ubiquitously transcribed at an early 
stage (embryo day 10.5), with the exception of 
the developing heart (Fig* 5c). Notably, Midi 
expression was found to be highest in the first 
and second branchial arches, along both the 
proximo-distal (Fig. Safi) and medio-lateral 
axes (Fig. 5c). We did not detect any expression 
signals above background level by using the 
sense probe as a control (data not shown).
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Fig. 2 Physical map of the Xp22.3 region containing the M ID I gene. The position, start codon and 
direction of transcription of the M IDI gene are indicated. The exon trapping products 6H and 10a are 
shown as short horizontal lines. The Xp22.3 breakpoint of the pericentric inversion (X)(p22.3q26) asso­
ciated with OS is indicated by a jagged vertical line, as are the deletion/translocation breakpoints of 
patients BA38, BA95 and BA333 (ref. 60). Cosmid clones are indicated as filled (LLNL library) or hollow 
(RLDB library) horizontal bars (ref. 28 and Cox et a/M subm itted). The genomic region illustrated is 
contained in YAC clone 184F6.
MIDI encodes a RING-finger protein
Analysis of the consensus MIDI  cDNA se­
quence showed that the predicted MIDI am ­
ino-acid sequence shares homology with a 
family of proteins containing a tripartite pro- 
tein-protein interaction motif consisting of a 
RING-finger, B-box (one or two copies) and
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Fig. 3 MIDI protein sequence, a, Predicted MIDI amtno- 
acid sequence. The conserved cysteine and histidine 
residues in the RING-finger and B-box domains are boxed. 
The predicted coiled-coil domain is underlined, as are the 
three conserved regions of the C-terminal domain. The in- 
frame 3-bp deletion (AM438) is shown in bold; the site of 
the 24-bp tandem duplication (1787ins24bp) is indicated 
by the site of a single base pair insertion (1744insG) is 
indicated by v , b, Multiple-sequence alignment of con­
served motifs in the C-terminal domain. Residues conserved 
in more than 50% of proteins are shown in bold. The pro­
teins MIDI, Ro/SSA, Efp, PWA33, RFP and Xnf7 all belong to 
the B-box family. Butyrophilin also contains the conserved 
C-terminal motifs, although it does not contain the other 
characteristic features of the B-box family.
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coiled-coil domains (Fig. 3a). The consensus RING-finger 
sequence contains seven conserved cysteine residues and a sin­
gle conserved histidine residue in the following format: 
CXXCX(9-27)CX(1-3)HXXCXXCX(4-48)CXXC, where X may 
be any amino acid32, MIDI also contains two copies of a B-box 
zinc-binding domain, immediately followed by a leucine-rich 
coiled-coil domain. The B-box consensus sequence consists of 
seven conserved cysteine/histidine residues. The first M IDI B- 
box contains an additional conserved cysteine residue (position 
137), present in a subset of tripartite domain-containing pro­
teins. An additional stretch of amino-acid conservation in the 
C-terminal region was also noted between MIDI and five-tri­
partite motif-containing proteins. The functional 
significance of this region is unknown. This con­
served C-terminal region is also present in bu ty ­
rophilin, an unrelated protein lacking all the 
characteristic elements of the tripartite m otif33 
(Fig. 3b and Discussion).
Mutation analysis in OS patients
To partly characterize the genomic structure of the 
MIDI  gene, we performed direct sequencing o f  cos-
mid clones U232B2, U11D6, U239F12 and U 8D 11, 
or of EcolU plasmid subclones derived from them, 
using oligonucleotides designed from the MIDI  
consensus cDNA sequence. Oligonucleotide pri­
mers were designed in the flanking intronic se­
quences of two characterized exons to allow PCR 
amplification and subsequent SSCP analysis o f  the 
MIDI  coding regions and splice sites from OS 
patients and controls. We performed preliminary 
mutation analysis of the two characterized exons 
on 22 independent OS families in which X-iinked 
inheritance was possible but not confirmed. Three 
SSCP band-shifts segregating with affected individ­
uals from three OS pedigrees were identified. The 
first band-shift was observed with a 246-bp PCR 
product (using primers TO-3835 and T0-3870) 
spanning nucleotides 1472-1633 of the coding 
region. The two other band-shifts were both  
observed with a 345-bp PCR product (using 
primers T0-3869 and T0-3825) spanning nuc­
leotides 1634-1844 of the coding region. Se­
quencing the MIDI  PCR products derived from 
affected individuals revealed three mutations, all o f  
which result in abnormalities in the C-terminal 
region of the MIDI protein (Fig. 3a). The first 
mutation to be detected (using primers TO-3835
------------- — and TO-3870) in an affected male (1.290, family
OSS) was an in-frame 3-bp deletion (AM438), re­
sulting in the absence of a methionine residue from 
the MIDI protein (Fig. 3a). On SSCP analysis, the band-shift 
caused by the deletion was seen to segregate with all five o f  the 
affected individuals tested and was absent in all six unaffected 
individuals in family OSS. The addition of a single G nucleotide 
(1745insG) was observed in an affected male (1644, family OS 16; 
Figs 3£z,6a). The resulting frameshift produces a premature stop 
codon at position 1795, truncating the MIDI  gene product by 131 
amino acids in the conserved C-terminal domain (Figs 3 ,^/?)* The 
affected mother (1642) was found to be heterozygous for the 
mutation (Fig. 6a). An affected male (1676, family OS20) dis­
played a tandem duplication of 24 bp (1787ins24bp), resulting in 
the insertion of eight amino acids (FIDSGRHL) at position 534 of
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Fig. 6 Mutations of M ID I in OS families, a, Family OS16, Sequence analysis reveals the addition of a single G nucleotide (arrow) in affected son, 1644, and 
affected heterozygous mother, 1642. Note presence of double peaks in female patient 1642 downstream of the insertion site due to the presence of both nor­
mal and out-of-frame alleles. WT, control wild-type allele, b, Family 0520. Sequence analysis reveals a 24-bp duplication (square brackets) in affected son, 1676, 
and affected heterozygous mother, 1674. Note presence of double peaks in patient 1674 downstream of the duplication due to the presence of both normal 
and mutant alleles. WT, control wild-type allele.
gating with the disease in a large pedigree19, and is mutated in 
three independent OS families. Among the mutations found, a 
duplication and an insertion create a major change in the MIDI 
protein product by disrupting the highly conserved C-terminal 
domain. In the first case, the mutation causes a duplication of 
eight amino acids within the second conserved C-terminal mo­
tif. In the second case, the 1-bp insertion produces a frameshift 
that causes premature termination of the MIDI protein and 
deletion of the last two C-terminal motifs. These mutations 
strongly support an important functional role for the C-terminal 
domain. This is a new concept, as most previous studies on pro­
teins bearing the tripartite motif have concentrated on the func­
tion of the RING finger and the B-box, not on the C-terminal 
region of these proteins.
MIDI is completely deleted in two female patients (BA95 and 
BA333) with de novo Xp22;Yql 1 translocations, resulting in very 
large (more than 10 Mb) terminal Xp deletions (ref. 31, pers. 
comm). The X-chromosome breakpoints of these two translo­
cations fall just centromeric to the 5' end of the gene (Fig. 2). 
These female patients show symptoms highly suggestive of OS, 
such as dysmorphic face, abnormal external genitalia, imperfo­
rate anus and developmental delay. Several of these anomalies 
— such as imperforate anus, hypertelorism, laryngeal web and 
cardiac malformations— have been reported in other females 
carrying even larger terminal deletions of Xp22 and displaying 
more complex phenotypes, such as microphthalmia with linear 
skin lesions and Aicardi or Goltz syndrome44”47. These findings 
suggest that the complex phenotype of these patients is due to a 
contiguous-gene syndrome, allowing for the first time the dis­
section of the clinical spectrum of these patients by attribution 
of some symptoms to deletions to MIDI.
Possible role of MIDI in midline development. Most symptoms 
of OS are due to midline fusion defects. For instance, widely 
spaced eyes may be produced by a failure of migration of the 
orbits towards the midline, clefts in the lip, palate and 
trachea/oesophagus by a defect in closure of the facial and pha­
ryngeal processes, and hypospadias by a defective fusion of ure­
thral folds. In general, these symptoms suggest a defective 
patterning of midline elements along the medio-lateral axis, 
resulting in an expansion of the midline. A number of genes 
active in midline patterning have been identified, and some of 
them have been implicated in human genetic disorders. For 
example, mutations in the zinc-fmger GLI3 gene cause Greig 
syndrome, which is characterized by hypertelorism and pre- and 
post-axial polydactyly48. GLI3 is negatively regulated by sonic 
hedgehog (shh)49, which is expressed in the midline structures of 
both axial mesoderm and the ventral neural tube50. Notably, 
mutations of SHH in humans cause a loss rather than an expan­
sion of midline tissue, resulting in holoprosencephaly, a combi­
nation of severe forebrain and midfacial defects51,52.
Proteins containing the RING-fmger and B-box domains are 
expressed from a very early stage during development. In particu­
lar, the Xenopus laevis Xnf7 gene is maternally expressed and is 
retained in the cytoplasm until the midblastula transition, when 
it re-enters the nucleus22“25. Northern-blot analysis of MIDI in 
fetal and adult human tissues revealed a broad pattern of expres­
sion. Preliminary data obtained by RNA in situ hybridization on
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whole-mount mouse embryos determined that Midi is almost 
ubiquitously expressed. We detected higher expression levels in 
the branchial arches, correlating with the defective patterning of 
the skeletal elements within the craniofacial structures.
Our data indicate that mutations in the gene encoding a novel 
member of the B-box family are responsible for X-linked OS. It 
could be anticipated that the study of the function and dysfunc­
tion of this gene in humans and model organisms will help clarify 
the mechanisms underlying the establishment and development 
of midline structures in vertebrates. Moreover, in identifying the 
MIDI gene implicated in OS, we have discovered a new aetio- 
logic factor in genetically determined mental retardation and 
cleft lip and palate. The search for genes homologous to MIDI 
could be instrumental in the discovery of the molecular basis of 
other syndromes associated with mental retardation and cleft lip 
a nd palate, including the chromosome 22-linked form of OS.
Methods
Patients with Opitz syndrome. Three families segregating OS were identi­
fied as carrying a mutation in M IDI. Detailed clinical findings, including 
photographs, were previously reported for kindred OS5 (refs 4,17). 
Kindred OS 16 consists of two affected brothers and their affected mother 
(Fig. 6a). The brothers have similar craniofacial findings, including bilat­
eral cleft lip and palate and other characteristic OS facial features, such as 
widely spaced eyes, widow’s peak and high nasal bridge (Fig, 1). Both have 
hypospadias; prominent costal arches, giving the thorax the appearance of 
a pectus excavatum; and increased space between the third and fourth fin­
gers. They have a mild developmental delay, especially in their speech. 
Both are hyperactive. Their mother has widely spaced eyes and is of nor­
mal intelligence. The proband in kindred OS20 (Fig. 6b) has hyper­
telorism, severe hypospadias (penile-scrotal hypospadias) and respiratory 
problems with inspiratory stridor due to trachaeomalacia (although no 
structural anomalies on examination). At 3 years of age, he was develop­
mental^ delayed, functioning at a level of mild mental retardation. His 
mother and half-sister both have hypertelorism and widow’s peak. All 
individuals participating in this study were clinically evaluated and their 
disease status was ascertained before initiation of molecular studies. 
Informed consent was obtained in accordance with the standards set by 
local review boards.
Sequence analysis. Sequence analysis was performed essentially as previ­
ously described53. C-terminal conserved motifs were detected with MEME 
software54. The predicted coiled-coil domain was generated with the 
COILS program53.
Characterization of MIDI genomic structure. Sequencing of MIDI cDNA 
clones and genomic clones was performed according to the manufacturer’s 
recommendations (Amersham). Positions of introns were determined by 
comparison of genomic and cDNA sequences.
Hybridization. Southern and northern hybridizations were performed as 
previously described57.
Whole-mount expression studies. In situ hybridization experiments on 
whole-mount mouse embryos were performed as previously described58. 
Clone ME 10.2 was used as a template for the digoxygenin-labelled RNA 
antisense and sense probes.
Mutation detection. Mutations were detected by SSCP analysis as previously 
described59. Samples showing variation were compared to those of other 
family members to assess allele segregation, and with at least 40 unrelated 
from people of European descent control samples to distinguish mutations 
from polymorphisms. PCR products amplified from total genomic DNA 
from patients demonstrating SSCP variants were run on 1% agarose gels and 
purified with the QIAquick gel extraction kit (Qiagen), Sequencing was per­
formed on an ABI sequencer. The following primers (5'—>3') were used to 
detect MIDI mutations; TO-3835, CTTGTGCCAAAGAACTGCAC; TO- 
3870, GAG C AG ATAAG AC ATG AC AG; TO-3869, TTG A A AATATGCTAT - 
TGGTTATG; and TO-3825, AGTACAGAATGAGATGTCC.
GenBank accession numbers. The sequences of the full-length human 
MIDI cDNA (Y13667) and the mouse partial Midi cDNA (Y14848) have 
been deposited in GenBank. Accession numbers for exon-trapping prod­
ucts 6H and 10a are Z44417, Z40343, F07967, F04215, R66237, 1167582, 
N25620, N34218, W90080, W90206, AA009434, AA009915, AA195713, 
AA195750, AA235258, AA242882 and AA2521647.
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